Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04430738 |
| Title | Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy for HER2+ Gastrointestinal Cancers |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Seattle Genetics, Inc. |
| Indications | |
| Therapies |
Fluorouracil + Leucovorin + Oxaliplatin + Trastuzumab + Tucatinib |
| Age Groups: | adult | senior |
| Covered Countries | USA |